# Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease

> **NCT07646652** · — · NOT_YET_RECRUITING · sponsor: **Stanford University** · enrollment: 40 (estimated)

## Conditions studied

- Lewy Body Disease

## Interventions

- **OTHER:** LBD Biomarker Education and Disclosure

## Key facts

- **NCT ID:** NCT07646652
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11
- **Primary completion:** 2030-11
- **Final completion:** 2030-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07646652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07646652, "Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07646652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*